These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33531687)

  • 1. The bovine dialysable leukocyte extract IMMUNEPOTENT CRP induces immunogenic cell death in breast cancer cells leading to long-term antitumour memory.
    Reyes-Ruiz A; Calvillo-Rodriguez KM; Martínez-Torres AC; Rodríguez-Padilla C
    Br J Cancer; 2021 Apr; 124(8):1398-1410. PubMed ID: 33531687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMMUNEPOTENT CRP induces DAMPS release and ROS-dependent autophagosome formation in HeLa and MCF-7 cells.
    Martínez-Torres AC; Reyes-Ruiz A; Calvillo-Rodriguez KM; Alvarez-Valadez KM; Uscanga-Palomeque AC; Tamez-Guerra RS; Rodríguez-Padilla C
    BMC Cancer; 2020 Jul; 20(1):647. PubMed ID: 32660440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bovine dialyzable leukocyte extract, immunepotent CRP, synergically enhances cyclophosphamide-induced breast cancer cell death, through a caspase-independent mechanism.
    Rivera-Lazarín AL; Martínez-Torres AC; de la Hoz-Camacho R; Guzmán-Aguillón OL; Franco-Molinaa MA; Rodríguez-Padilla C
    EXCLI J; 2023; 22():131-145. PubMed ID: 36998710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.
    Rodríguez-Salazar MDC; Franco-Molina MA; Mendoza-Gamboa E; Martínez-Torres AC; Zapata-Benavides P; López-González JS; Coronado-Cerda EE; Alcocer-González JM; Tamez-Guerra RS; Rodríguez-Padilla C
    Oncol Lett; 2017 Jul; 14(1):844-852. PubMed ID: 28693241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell death induced by cytotoxic CD8
    Jaime-Sanchez P; Uranga-Murillo I; Aguilo N; Khouili SC; Arias MA; Sancho D; Pardo J
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32241808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer.
    Si Y; Yue J; Liu Z; Li M; Du F; Wang X; Dai Z; Hu N; Ju J; Gao S; Wang X; Yuan P
    Int J Nanomedicine; 2021; 16():1913-1926. PubMed ID: 33707946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMMUNEPOTENT CRP plus doxorubicin/cyclophosphamide chemotherapy remodel the tumor microenvironment in an air pouch triple-negative breast cancer murine model.
    Santana-Krímskaya SE; Franco-Molina MA; Zárate-Triviño DG; Prado-García H; Zapata-Benavides P; Torres-Del-Muro F; Rodríguez-Padilla C
    Biomed Pharmacother; 2020 Jun; 126():110062. PubMed ID: 32172064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells.
    Calvillo-Rodríguez KM; Mendoza-Reveles R; Gómez-Morales L; Uscanga-Palomeque AC; Karoyan P; Martínez-Torres AC; Rodríguez-Padilla C
    Oncoimmunology; 2022; 11(1):2054305. PubMed ID: 35402082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMMUNEPOTENT CRP increases intracellular calcium through ER-calcium channels, leading to ROS production and cell death in breast cancer and leukemic cell lines.
    Lorenzo-Anota HY; Reyes-Ruiz A; Calvillo-Rodríguez KM; Mendoza-Reveles R; Urdaneta-Peinado AP; Alvarez-Valadez KM; Martínez-Torres AC; Rodríguez-Padilla C
    EXCLI J; 2023; 22():352-366. PubMed ID: 37223080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models.
    Humeau J; Lévesque S; Kroemer G; Pol JG
    Methods Mol Biol; 2019; 1884():297-315. PubMed ID: 30465212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8
    Yu Z; Liu W; He Y; Sun M; Yu J; Jiao X; Han Q; Tang H; Zhang B; Xian Y; Qi J; Gong J; Xin W; Shi G; Shan F; Zhang R; Li J; Wei M
    J Hematol Oncol; 2021 Apr; 14(1):71. PubMed ID: 33910591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.
    Wang B; Zaidi N; He LZ; Zhang L; Kuroiwa JM; Keler T; Steinman RM
    Breast Cancer Res; 2012 Mar; 14(2):R39. PubMed ID: 22397502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD47 agonist peptide PKHB1 induces immunogenic cell death in T-cell acute lymphoblastic leukemia cells.
    Uscanga-Palomeque AC; Calvillo-Rodríguez KM; Gómez-Morales L; Lardé E; Denèfle T; Caballero-Hernández D; Merle-Béral H; Susin SA; Karoyan P; Martínez-Torres AC; Rodríguez-Padilla C
    Cancer Sci; 2019 Jan; 110(1):256-268. PubMed ID: 30460757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis.
    Li Y; Song Z; Han Q; Zhao H; Pan Z; Lei Z; Zhang J
    Mol Oncol; 2022 Aug; 16(15):2861-2880. PubMed ID: 35665592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK12/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer.
    Li Y; Zhang H; Li Q; Zou P; Huang X; Wu C; Tan L
    Cancer Lett; 2020 Dec; 495():12-21. PubMed ID: 32941949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.
    Hennies CM; Reboulet RA; Garcia Z; Nierkens S; Wolkers MC; Janssen EM
    Clin Exp Immunol; 2011 Mar; 163(3):381-91. PubMed ID: 21235535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A marine-derived small molecule induces immunogenic cell death against triple-negative breast cancer through ER stress-CHOP pathway.
    Wen H; Zhong Y; Yin Y; Qin K; Yang L; Li D; Yu W; Yang C; Deng Z; Hong K
    Int J Biol Sci; 2022; 18(7):2898-2913. PubMed ID: 35541893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.